21 May 2013
Keywords: Pfizer, Neurontin, Epilepsy, NEJM, Marketing, Off-label use
Article | 12 November 2009
The world’s largest drugmaker, USA-based Pfizer, denies that it may have altered or omitted unfavorable study results relating to ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.